MARSHALL WACE, LLP - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$539,952
-85.1%
32,944
-83.2%
0.00%
-87.5%
Q3 2022$3,618,000
+355.7%
195,545
+471.7%
0.01%
+100.0%
Q1 2019$794,000
+22.3%
34,202
+10.7%
0.00%
-42.9%
Q4 2018$649,00030,8980.01%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders